Medidata 연구 연합

과학적 협업.
입증된 임상 근거.

의학 발전은 단절된 환경에서 이루어지지 않습니다. 획기적인 발전을 위해서는 연결된 데이터, 과학적 전문성, 그리고 엄격한 연구가 함께 어우러져야 합니다.

Medidata 연구 연합은 선도적인 학술 연구자들과 Medidata의 임상시험 데이터 및 기술을 결합하여 임상적으로 의미 있는 인사이트를 생성하고 유망한 치료법에 대한 접근성을 확대합니다.

Video transcript: Metadata was founded in nineteen ninety nine as a scientific company by scientists. To further honor our commitment to clinical research, we created a multi sector collaborative forum called the Metadata Research Alliance. Its mission is threefold. One is bringing together physician scientists and industry leaders through our strategic framework to advance medical breakthroughs by two, leveraging our expertise in data and analytics, especially in areas of unmet clinical need. And three, the goal of conducting cutting edge research by collaborating with our partners to bridge insights from data into clinical practice. We created the Research Alliance to expand our reach and relevance to the scientific, medical and patient communities by providing access to these robust data to ensure that they can be used to transform patient care and propel the field forward with our academic physician scientist collaborators. The research alliance is founded upon scientific exploration to partner with the clinical trial ecosystem's key opinion leaders with scientific rigor to bolster our impact and to design and execute safer trials for patients. We're continuing to grow our network collaborators and expand into new disease areas, building an even richer and more robust community. By bringing these pieces together, leading data, expertise, and the network of collaborators, we can work together to expand treatment options for the patients who need them most. This is the virtuous cycle of scientific and clinical engagement that we envision.
교차 의뢰자 임상시험
38 K+
환자
12 M+
국가
140 +

동료 심사 연구

Medidata 연구 연합은 업계 최대 규모의 데이터 세트 중 하나를 활용하여 동료 심사 연구를 수행합니다. 우리의 연구는 유수의 저널과 글로벌 과학 포럼에 게재되어, 임상 현장에서 치료법이 평가되고 적용되는 방식에 영향을 미치고 있습니다.

강력한 데이터

Medidata Research Alliance는 업계 최대 규모의 과거 임상시험 데이터세트 중 하나를 활용하며, 여기에는 Medidata Platform 내에서 수집 및 검증된 원래의 평가변수와 완전한 공변량 정보가 포함됩니다. 이러한 깊이는 다양한 인구 집단에 걸쳐 치료 효능, 안전성 프로파일, 환자 결과에 대한 엄격한 평가를 지원합니다.

팩트 시트 보기
Video transcript: What does solve the impossible mean to me? Solve the impossible? It's delivering better treatments against overwhelming odds. It's the difference between running out of time and getting there sooner. It's being able to see the problems and deal with them before they happen. It's about taking control of data. That's pouring in from every direction. It's when you work with people who can say, here's how. Here's how. There are a lot of uncertainties when you're planning and running a clinical trial. And what we do in intelligent trials is help our customers de risk their trials by providing insights that help them make better decisions. Roughly half of the world's clinical trials are run on our platform and we use that data to be able to provide answers that our customers otherwise would not have been able to get. Anything that can improve the planning and the monitoring to improve the probability of success is a huge deal, both for our customers and also for the patients. It's huge when patients are waiting for a new drug and we are able to help bring a successful drug program to conclusion faster. After business school, I wanted to be able to influence the core decisions that organizations were making, and that's where I got into data science and discovered the power of analytics to improve decision making. Our team is composed of people who are really passionate about what they do. They're problem solvers. The opportunity that we have here at Metadata is helping our customers solve some of their toughest problems. I lead the team for Metadata Link. We connect clinical trial data with real world data. By joining these two data sets or two worlds together, we have so much more perspective on the patient as they live their everyday life, as they go to a doctor's office or hospital. Traditionally, do this, you would have to do data linkage at the sites. It's quite burdensome and it's not scalable. Metadata's Unified Clinical Cloud makes it so seamless. Seamless means that it's less burdensome for sponsors and patients. Instead of running a very lengthy trial, you could run part of it as a clinical trial and do the remaining evidence generation through the real world data that you collect. Medidata runs a large portion of the world's clinical trials and bringing metadata linked to this is really game changing. The inspiration around creating the Metadata AI Labs team was to ensure that we had a group focused on helping our clients really understand and unlock the value of our data. My team is the most direct link to a client while they're using our products. And collaboration is so important, not so much just the working together, but recognizing that it takes a village. We obviously have the data, have the product ingenuity, but our clients are our users and they're the ones that are implementing and delivering on initiatives. I got my master's in biology and I ended up with a job at a CRO and really just fell in love with the clinical trial industry. The rewarding aspect of what my team does is really seeing our clients improve and explore new ideas with our recently released diversity module being a really good example. The impact of improving diversity in clinical trials is to ensure that the patients that will ultimately be taking the drug are clearly represented in the clinical trial. I work at Metadata AI in the Commercial Data Solutions team. A billion dollars invested in research and a decade potentially later, our customers need to figure out a way to get this product to the patients in the market in the real world and that's where we come in. Customers only get one shot at launching, and the first six months of their launch usually predict the trajectory of a product in the market. We work to seize that decisive moment. We've put a lot of time and effort and thought into building a platform for the life sciences that stitches together very complex, messy data so our customers have that singular source of truth to drive their business decisions. And the type of data we get, it's very rich patient level data. Are they happy with how their treatment's progressing? Are the physicians prescribing like they should? We tease information from all of that to say, what can we do to change that behavior to better improve the patient outcome? We are market leaders, but no one ever stops asking what's next? What else can we do? Our team is accustomed to rolling up their sleeves, solving problems, supporting our customers. It's a new adventure every day. There's so much that's still undiscovered and not solved when it comes to human health. The future will bring more tough problems that we will solve. What does solve the impossible mean to me? It's changing the way we run clinical trials and generate evidence. We try to move human health forward by focusing on the patient and the data that we use to drive our customers business decisions all circles back to the patient. I'm proud of my work here because it means something. The technology, the innovation, and the humanity. I think the possibilities are limitless.
Video thumbnail

협업 프레임워크

수준 높은 임상 과학을 발전시키는 구조화되고 확장 가능한 연구 모델을 만나보세요. Medidata Research Alliance는 선도적인 학계 전문가들과 Medidata의 임상의, 생물통계학자, 전직 규제 당국 관계자, 데이터 과학자들을 연결하여 귀사의 연구팀의 연장선상에서 가설을 엄격하게 테스트하고 임상 혁신을 가속화하는 증거를 생성합니다.

학계 파트너 기관

Medidata의 개별 학계 파트너들은 세계 유수의 학술 기관 출신입니다.

더 많은 리소스


더 심층적인 가이드와 관련 자료를 살펴보세요.

모든 리소스 보기

상담하기

질문이 있으신가요? 가격 정보 또는 다음 단계에 대해 알아보고 싶으신가요? 지금 전문가와 상담하세요. 저희 팀이 도와드리겠습니다.

문의하기